Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
BMJ Open|May 25, 2022
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysisJoseph E Ebinger, Sandy Joung, Yunxian Liu, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Nature|September 4, 2024
An aberrant immune-epithelial progenitor niche drives viral lung sequelaeHarish Narasimhan, In Su Cheon, Wei Qian, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
The Journal of Physical Chemistry Letters|April 8, 2017
Performance Characterization of Dye-Sensitized Photovoltaics under Indoor LightingChia-Yuan Chen, Zih-Hong Jian, Shih-Han Huang, et al.
JAMA|April 11, 2023
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical TrialsWesley H Self, Matthew S Shotwell, Kevin W Gibbs, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
Pageof 43